Document is current
Any future updates will be listed below
-
Authors
Socrates, Adam J. https://orcid.org/0009-0002-3742-351X
Mullins, Niamh https://orcid.org/0000-0001-8021-839X
Gur, Ruben C. https://orcid.org/0000-0002-9657-1996
Gur, Raquel E.
Stahl, Eli https://orcid.org/0000-0002-1192-0561
O’Reilly, Paul F. https://orcid.org/0000-0001-7515-0845
Reichenberg, Abraham
Jones, Hannah https://orcid.org/0000-0002-5883-9605
Zammit, Stanley
Velthorst, Eva
-
Funding
Funding for this research was provided by:
Beatrice and Samuel A. Seaver Foundation
Wellcome Trust (217065/Z/19/Z))
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01 MH128971)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01 MH119219)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH128971)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
Icahn School of Medicine at Mount Sinai
University of Pennsylvania
University of Bristol
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
- License Information
-
More Information
Article History
Received: 22 February 2023
Revised: 2 May 2024
Accepted: 16 May 2024
First Online: 30 May 2024
Competing interests
: ES is a current employee of Regeneron Pharmaceuticals, Inc.
: All participants provided written informed consent and the current study was ethically approved by the UK Biobank Ethics and Governance Council (REC reference 11/NW/0382; UK Biobank application reference 18177). Ethical approval for the study was also obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees.
